@article{48c0673fba14442fbfd028af5aab7100,
title = "Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial",
author = "Sehn, \{L H\} and N Chua and J Mayer and G Dueck and M Trneny and K Bouabdallah and N Fowler and V Delwail and O Press and G Salles and J Gribben and A Lennard and Elly Lugtenburg and N Dimier and E Wassner-Fritsch and G Fingerle-Rowson and BD Cheson",
year = "2016",
doi = "10.1016/s1470-2045(16)30097-3",
language = "Undefined/Unknown",
volume = "17",
pages = "1081--1093",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Elsevier Ltd.",
number = "8",
}